Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to site content Skip directly to page options
CDC Home

Improving Treatment Protocols

California Cancer Registry

The California Cancer Registry (CCR) initiated a descriptive study to characterize a specific type of breast cancer known as "triple-negative" (estrogen-receptor negative, progesterone-receptor negative, and human epidermal growth factor receptor-2 negative) breast cancer. This type of breast cancer is not amenable to any form of endocrine therapy, and efforts to develop targeted therapies are underway.

The results showed that the following factors were associated with triple-negative breast cancer—

  • Younger age at diagnosis.
  • African American race or ethnicity.
  • More advanced stage at diagnosis.
  • Lack of cell type differentiation.
  • Lower socioeconomic status.
  • Shortened survival.

The CCR now requires detailed information about these tumor markers.

 
Contact Us:
  • Centers for Disease Control and Prevention
    Division of Cancer Prevention and Control
    c/o CDC Warehouse
    3719 N Peachtree Rd
    Building 100 MS F-76
    Chamblee GA 30341
  • 800-CDC-INFO
    (800-232-4636)
    TTY: (888) 232-6348
  • Contact CDC-INFO
USA.gov: The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Rd. Atlanta, GA 30333, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC–INFO
A-Z Index
  1. A
  2. B
  3. C
  4. D
  5. E
  6. F
  7. G
  8. H
  9. I
  10. J
  11. K
  12. L
  13. M
  14. N
  15. O
  16. P
  17. Q
  18. R
  19. S
  20. T
  21. U
  22. V
  23. W
  24. X
  25. Y
  26. Z
  27. #